|
1
|
Martin JD, Fukumura D, Duda DG, Boucher Y
and Jain RK: Reengineering the tumor microenvironment to alleviate
hypoxia and overcome cancer heterogeneity. Cold Spring Harb
Perspect Med. 6:a0270942016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang Q, Liang X, Ren T, Huang Y, Zhang H,
Yu Y, Chen C, Wang W, Niu J, Lou J and Guo W: The role of
tumor-associated macrophages in osteosarcoma
progression-therapeutic implications. Cell Oncol (Dordr).
44:525–539. 2021. View Article : Google Scholar
|
|
3
|
Lao L, Fan S and Song E: Tumor associated
macrophages as therapeutic targets for breast cancer. Adv Exp Med
Biol. 1026:331–370. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu Z, Zhang H, Chen B, Liu X, Zhang S,
Zong Z and Gao M: PD-L1-mediated immunosuppression in glioblastoma
is associated with the infiltration and M2-polarization of
tumor-associated macrophages. Front Immunol. 11:5885522020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cersosimo F, Lonardi S, Bernardini G,
Telfer B, Mandelli GE, Santucci A, Vermi W and Giurisato E:
Tumor-associated macrophages in osteosarcoma: From mechanisms to
therapy. Int J Mol Sci. 21:52072020. View Article : Google Scholar :
|
|
6
|
Macciò A, Gramignano G, Cherchi MC, Tanca
L, Melis L and Madeddu C: Role of M1-polarized tumor-associated
macrophages in the prognosis of advanced ovarian cancer patients.
Sci Rep. 10:60962020PubMed/NCBI
|
|
7
|
Wang X, Li X and Wang X: Identification of
immune microenvironment subtypes that predicted the prognosis of
patients with ovarian cancer = Identification of immune
microenvironment subtypes that predicted the prognosis of patients
with ovarian cancer. J Cell Mol Med. 25:4053–4061. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Honkanen TJ, Tikkanen A, Karihtala P,
Mäkinen M, Väyrynen JP and Koivunen JP: Prognostic and predictive
role of tumour-associated macrophages in HER2 positive breast
cancer. Sci Rep. 9:109612019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mills CD, Kincaid K, Alt JM, Heilman MJ
and Hill AM: M-1/M-2 macrophages and the Th1/Th2 paradigm. J
Immunol. 164:6166–6173. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gordon S and Martinez FO: Alternative
activation of macrophages: Mechanism and functions. Immunity.
32:593–604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Komohara Y, Fujiwara Y, Ohnishi K and
Takeya M: Tumor-associated macrophages: Potential therapeutic
targets for anti-cancer therapy. Adv Drug Deliv Rev. 99:180–185.
2016. View Article : Google Scholar
|
|
13
|
Mantovani A, Marchesi F, Malesci A, Laghi
L and Allavena P: Tumour-associated macrophages as treatment
targets in oncology. Nat Rev Clin Oncol. 14:399–416. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shu Y and Cheng P: Targeting
tumor-associated macrophages for cancer immunotherapy. Biochim
Biophys Acta Rev Cancer. 1874:1884342020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davis BN and Hata A: Regulation of
MicroRNA biogenesis: A miRiad of mechanisms. Cell Commun Signal.
7:182009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fathullahzadeh S, Mirzaei H, Honardoost
MA, Sahebkar A and Salehi M: Circulating microRNA-192 as a
diagnostic biomarker in human chronic lymphocytic leukemia. Cancer
Gene Ther. 23:327–332. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Keshavarzi M, Sorayayi S, Jafar Rezaei M,
Mohammadi M, Ghaderi A, Rostamzadeh A, Masoudifar A and Mirzaei H:
MicroRNAs-based imaging techniques in cancer diagnosis and therapy.
J Cell Biochem. 118:4121–4128. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Khalife H, Skafi N, Fayyad-Kazan M and
Badran B: MicroRNAs in breast cancer: New maestros defining the
melody. Cancer Genet. 246-247:18–40. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu G and Abraham E: MicroRNAs in immune
response and macrophage polarization. Arterioscler Thromb Vasc
Biol. 33:170–177. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Essandoh K, Li Y, Huo J and Fan GC:
MiRNA-mediated macrophage polarization and its potential role in
the regulation of inflammatory response. Shock. 46:122–131. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Graff JW, Dickson AM, Clay G, McCaffrey AP
and Wilson ME: Identifying functional microRNAs in macrophages with
polarized phenotypes. J Biol Chem. 287:21816–21825. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang S, Ge W, Zou G, Yu L, Zhu Y, Li Q,
Zhang Y, Wang Z and Xu T: MiR-382 targets GOLM1 to inhibit
metastasis of hepatocellular carcinoma and its down-regulation
predicts a poor survival. Am J Cancer Res. 8:120–131.
2018.PubMed/NCBI
|
|
23
|
Xu M, Jin H, Xu CX, Sun B, Song ZG, Bi WZ
and Wang Y: miR-382 inhibits osteosarcoma metastasis and relapse by
targeting Y box-binding protein 1. Mol Ther. 23:89–98. 2015.
View Article : Google Scholar :
|
|
24
|
Yao H, Xia D, Li ZL, Ren L, Wang MM, Chen
WS, Hu ZC, Yi GP and Xu L: MiR-382 functions as tumor suppressor
and chemosensitizer in colorectal cancer. Biosci Rep.
39:BSR201804412019. View Article : Google Scholar :
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Taki M, Abiko K, Ukita M, Murakami R,
Yamanoi K, Yamaguchi K, Hamanishi J, Baba T, Matsumura N and Mandai
M: Tumor immune microenvironment during epithelial-mesenchymal
transition. Clin Cancer Res. 27:4669–4679. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen
L, Xiao HL, Wang B, Yi L, Wang QL, et al: Tumor-associated
microglia/macrophages enhance the invasion of glioma stem-like
cells via TGF-β1 signaling pathway. J Immunol. 189:444–453. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chaudhury A, Hussey GS, Ray PS, Jin G, Fox
PL and Howe PH: TGF-beta-mediated phosphorylation of hnRNP E1
induces EMT via transcript-selective translational induction of
Dab2 and ILEI. Nat Cell Biol. 12:286–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai J, Xia L, Li J, Ni S, Song H and Wu X:
Tumor-associated macrophages derived TGF-β-induced epithelial to
mesenchymal transition in colorectal cancer cells through
Smad2,3-4/Snail signaling pathway. Cancer Res Treat. 51:252–266.
2019. View Article : Google Scholar
|
|
30
|
Liu CY, Xu JY, Shi XY, Huang W, Ruan TY,
Xie P and Ding JL: M2-polarized tumor-associated macrophages
promoted epithelial-mesenchymal transition in pancreatic cancer
cells, partially through TLR4/IL-10 signaling pathway. Lab Invest.
93:844–854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lei Y, Zhou H, Dai M, Jin X and Ming J:
Effects of Mir-382 on biological characteristics of triple negative
breast cancer cell line 4T1 through PGC-1α. J Third Mil Med Univ.
41:1415–1422. 2019.
|
|
32
|
Jin X, Ni TG, Wang N, Luo H, Lei Y and
Ming J: Mechanism of mitochondria-mediated PGC-1α in macrophage
polarization. J Third Mil Med Univ. 41:56–62. 2019.
|
|
33
|
Dai M, Jin X, Lei YY and Ming: Effect of
miR-382 overexpressing tumor-associated macrophages on biological
properties of triple-negative breast cancer 4T1 cells. J Third Mil
Med Univ. 40:1375–1382. 2018.
|
|
34
|
Hobson-Gutierrez SA and Carmona-Fontaine
C: The metabolic axis of macrophage and immune cell polarization.
Dis Model Mech. 11:dmm0344622018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Krawczyk CM, Holowka T, Sun J, Blagih J,
Amiel E, DeBerardinis RJ, Cross JR, Jung E, Thompson CB, Jones RG
and Pearce EJ: Toll-like receptor-induced changes in glycolytic
metabolism regulate dendritic cell activation. Blood.
115:4742–4749. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao M, Wang Y, Li L, Liu S, Wang C, Yuan
Y, Yang G, Chen Y, Cheng J, Lu Y and Liu J: Mitochondrial ROS
promote mitochondrial dysfunction and inflammation in ischemic
acute kidney injury by disrupting TFAM-mediated mtDNA maintenance.
Theranostics. 11:1845–1863. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Campbell CT, Kolesar JE and Kaufman BA:
Mitochondrial transcription factor A regulates mitochondrial
transcription initiation, DNA packaging, and genome copy number.
Biochim Biophys Acta. 1819:921–929. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Klinge CM: Estrogenic control of
mitochondrial function. Redox Biol. 31:1014352020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cruz-Bermúdez A, Laza-Briviesca R,
Vicente-Blanco RJ, García-Grande A, Coronado MJ, Laine-Menéndez S,
Palacios-Zambrano S, Moreno-Villa MR, Ruiz-Valdepeñas AM, Lendinez
C, et al: Cisplatin resistance involves a metabolic reprogramming
through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS
inhibition. Free Radic Biol Med. 135:167–181. 2019. View Article : Google Scholar
|
|
40
|
Ferlay J, Colombet M, Soerjomataram I,
Parkin DM, Piñeros M, Znaor A and Bray F: Cancer statistics for the
year 2020: An overview. Int J Cancer. Apr 5–2021.Epub ahead of
print. View Article : Google Scholar
|
|
41
|
Butowski N, Colman H and De Groot JF:
Orally administered colony stimulating factor 1 receptor inhibitor
PLX3397 in recurrent glioblastoma: An Ivy Foundation Early Phase
Clinical Trials Consortium phase II study. Neuro Oncol. 18:557–564.
2016. View Article : Google Scholar :
|
|
42
|
Edelman MJ, Wang X, Hodgson L, Cheney RT,
Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J,
et al: Phase III randomized, placebo-controlled, double-blind trial
of celecoxib in addition to standard chemotherapy for advanced
non-small-cell lung cancer with cyclooxygenase-2 overexpression:
CALGB 30801 (Alliance). J Clin Oncol. 35:2184–2192. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Reid T, Oronsky B, Scicinski J, Scribner
CL, Knox SJ, Ning S, Peehl DM, Korn R, Stirn M, Carter CA, et al:
Safety and activity of RRx-001 in patients with advanced cancer: A
first-in-human, open-label, dose-escalation phase 1 study. Lancet
Oncol. 16:1133–1142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chatterjee B, Saha P, Bose S, Shukla D,
Chatterjee N, Kumar S, Tripathi PP and Srivastava AK: MicroRNAs: As
critical regulators of tumor-associated macrophages. Int J Mol Sci.
21:71172020. View Article : Google Scholar
|
|
45
|
Gholamin S, Mirzaei H, Razavi SM,
Hassanian SM, Saadatpour L, Masoudifar A, ShahidSales S and Avan A:
GD2-targeted immunotherapy and potential value of circulating
microRNAs in neuroblastoma. J Cell Physiol. 233:866–879. 2018.
View Article : Google Scholar
|
|
46
|
Yang J, Zhang Z, Chen C, Liu Y, Si Q,
Chuang TH, Li N, Gomez-Cabrero A, Reisfeld RA, Xiang R and Luo Y:
MicroRNA-19a-3p inhibits breast cancer progression and metastasis
by inducing macrophage polarization through downregulated
expression of Fra-1 proto-oncogene. Oncogene. 33:3014–3023. 2014.
View Article : Google Scholar
|
|
47
|
Banerjee S, Xie N, Cui H, Tan Z, Yang S,
Icyuz M, Abraham E and Liu G: MicroRNA let-7c regulates macrophage
polarization. J Immunol. 190:6542–6549. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Huang C, Liu XJ, Qun Zhou, Xie J, Ma TT,
Meng XM and Li J: MiR-146a modulates macrophage polarization by
inhibiting Notch1 pathway in RAW264.7 macrophages. Int
Immunopharmacol. 32:46–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lei J, Fu Y, Zhuang Y, Zhang K and Lu D:
miR-382-3p suppressed IL-1β induced inflammatory response of
chondrocytes via the TLR4/MyD88/NF-κB signaling pathway by directly
targeting CX43. J Cell Physiol. 234:23160–23168. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Huang J, Wang F, Argyris E, Chen K, Liang
Z, Tian H, Huang W, Squires K, Verlinghieri G and Zhang H: Cellular
microRNAs contribute to HIV-1 latency in resting primary CD4+ T
lymphocytes. Nat Med. 13:1241–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang X, Xue N, Zhao S, Shi Y, Ding X and
Fang Y: Upregulation of miR-382 contributes to renal fibrosis
secondary to aristolochic acid-induced kidney injury via PTEN
signaling pathway. Cell Death Dis. 11:6202020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhou H, Wang Y, Lin Z and Ming J:
Mir-382-5p affects the polarization of breast cancer
tumor-associated macrophages through the Akt/mTOR signaling
pathway. J Third Mil Med Univ. 43:1358–1365. 2021.
|
|
53
|
Chawla A: Control of macrophage activation
and function by PPARs. Circ Res. 106:1559–1569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Niu Z, Shi Q, Zhang W, Shu Y, Yang N, Chen
B, Wang Q, Zhao X, Chen J, Cheng N, et al: Caspase-1 cleaves PPARγ
for potentiating the pro-tumor action of TAMs. Nat Commun.
8:7662017. View Article : Google Scholar
|
|
55
|
Liu Y, Xu R, Gu H, Zhang E, Qu J, Cao W,
Huang X, Yan H, He J and Cai Z: Metabolic reprogramming in
macrophage responses. Biomark Res. 9:12021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Vazquez F, Lim JH, Chim H, Bhalla K,
Girnun G, Pierce K, Clish CB, Granter SR, Widlund HR, Spiegelman BM
and Puigserver P: PGC1α expression defines a subset of human
melanoma tumors with increased mitochondrial capacity and
resistance to oxidative stress. Cancer Cell. 23:287–301. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Bost F and Kaminski L: The metabolic
modulator PGC-1α in cancer. Am J Cancer Res. 9:198–211. 2019.
|
|
58
|
Abdalla HB, Napimoga MH, Lopes AH, de
Macedo Maganin AG, Cunha TM, Van Dyke TE and Clemente Napimoga JT:
Activation of PPAR-γ induces macrophage polarization and reduces
neutrophil migration mediated by heme oxygenase 1. Int
Immunopharmacol. 84:1065652020. View Article : Google Scholar
|
|
59
|
Zhang X, Zhang Y, Meng Q, Sun H, Wu S, Xu
J, Yun J, Yang X, Li B, Zhu H, et al: MicroRNA-382-5p is involved
in pulmonary inflammation induced by fine particulate matter
exposure. Environ Pollut. 262:1142782020. View Article : Google Scholar : PubMed/NCBI
|
